跳至主要内容
临床试验/KCT0008098
KCT0008098招募中未知

Prediction of the Treatment Response of Sacubitril/Valsartan in Patients with Heart Failure

Seoul National University Hospital0 个研究点目标入组 3,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients with a diagnosis of HF and prescribed with sacubitril/valsartan, and with following conditions:
  • (1) left ventricular ejection fraction (LVEF) =40%
  • (2) on an ACEI or an ARB at a stable dose, with standard medical therapy (beta blockers and mineralocorticoid antagonists), for at least 4 weeks
  • (3) hospitalized for acutely decompensated heart failure with reduced ejection fraction, and hemodynamically stabilized, regardless of the preceding use of ACEI or ARB

排除标准

  • (1) Patients <19 years of age
  • (2) Patients with active malignancy or those who underwent surgery for malignancy within 5 years of enrollment
  • (3) Paitents whose medical records cannot confirm the occurrence of cardiovascular events or death

研究者

相似试验